Intracavernous self-injection of prostaglandin E1 in the treatment of erectile dysfunction

International Journal of Impotence Research

Volumn 11, Issue 1, 1999, Pages 21-24

  Kunelius, P ^a   Lukkarinen, O ^b  

^a UNIVERSITY OF OULU   (Finland)

^b NONE

Author keywords

Erectile dysfunction; Long term results; Prostaglandin E1; Self injection

Indexed keywords

PROSTAGLANDIN E1; VASOACTIVE AGENT;

ADULT; AGED; ARTICLE; CLINICAL EXAMINATION; CLINICAL TRIAL; COITUS; ECHOGRAPHY; EJACULATION; ERECTILE DYSFUNCTION; FOLLOW UP; HEMATOMA; HUMAN; INTRACAVERNOUS DRUG ADMINISTRATION; LIBIDO; MAJOR CLINICAL STUDY; MALE; ORGASM; PATIENT SATISFACTION; PENIS ERECTION; PRIAPISM; PRIORITY JOURNAL; QUESTIONNAIRE; SELF MEDICATION; SEXUAL BEHAVIOR;

EID: 0033035456     PISSN: 09559930     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ijir.3900377     Document Type: Article

References (20)

1. National Institutes of Health. Impotence. Consensus development conference statement. Int J Impot Res 1993; 5: 181.
2. Andersson KE, Homlquist F, Wagner G. Pharmacology of drugs used for treatment of erectile dysfunction and priapism. Int J Impot Res 1991; 3: 155-172.
3. Ravnik-Oblak M, et al. Intracavernous injection of prostaglandin E1 in impotent diabetic men. Int J Impot Res 1990; 2: 143-150.
4. Schramek P, Waldhauser M. Dose-dependent effect and side-effect of prostaglandin E1 in erectile dysfunction. Br J Clin Pharmacol 1989; 28: 567-571.
5. Stackl W, Hasun R, Marberger M. Intracavernous injection of prostaglandin E1 in impotent men. J Urol 1988; 140: 66-68.
6. Chen J, et al. Peyronie's-like plaque after penile injection of prostaglandin E1. J Urol 1994; 152: 961-962.
7. Fouda A, et al. Priapism: an avoidable complication of pharmacologically induced erection. J Urol 1989; 142: 995-997.
8. Gerber GS, Levine LA. Pharmacological erection program using prostaglandin E1. J Urol 1991; 146: 786-789.
9. Govier FE, et al. Experience with triple-drug therapy in a pharmacological erection program. J Urol 1993; 150: 1822-1824.
10. Schramek P, Plas EG, Hubner WA. Intracavernous injection of prostaglandin E1 plus procaine in the treatment of erectile dysfunction. J Urol 1994; 152: 1108-1110.
11. McMahon CG. The return of spontaneous erections after self-injection of prostaglandin E1. Int J Impot Res 1992; 4: 179-186.
12. Sharlip ID. Does natural erectile function improve following intracavernous injections of vasoactive drugs? Int J Impot Res 1997; 9: 193-196.
13. Virag R, et al. Intracavernous self-injection of vasoactive drugs in the treatment of impotence: 8-year experience with 615 cases. J Urol 1991; 145: 287-293.
14. Sister MP. Prostaglandin E1 erectile dysfunction: 20 months of experience with 483 patients in a self-injection program. Int J Impot Res 1990; 2: 287-288.
15. Hwang TI-S, Yang C, Ho WL. Histopathological changes of corpora cavernosa after long term intracavernous injection. Eur Urol 1991; 20: 301-306.
16. Porst H. The rationale for prostaglandin E1 in erectile failure: a survey of worldwide experience. J Urol 1996; 155: 802-815.
17. Hwang TI-S, et al. Impotence evaluated by the use of prostaglandin E1. J Urol 1989; 141: 1357-1359.
18. Lundberg L, Olsson J-O, Kihl B. Long-term experience of self-injection therapy with prostaglandin E1 for erectile dysfunction. Scand J Urol Nephrol 1996; 30: 395-397.
19. Moriel EZ, Rajfer J. Sodium bicarbonate alleviates penile pain induced by intracavernous injections for erectile dysfunction. J Urol 1993; 149: 1299-1300.
20. Hasmat AI, Abrahams J, Fani K, Nostrand I. A lethal complication of papaverine-induced priapism. J Urol 1991; 145: 146-147.